Predictor of Early Remission of Diabetic Macular Edema under As-Needed Intravitreal Ranibizumab

The early remission of diabetic macular edema (DME) often occurs in eyes treated with anti-vascular endothelial growth factor (VEGF) treatment. We retrospectively reviewed and characterized eyes with early remission of DME at six months in 80 eyes under pro re nata (PRN) intravitreal ranibizumab (IV...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshitake, Tatsuya, Murakami, Tomoaki, Suzuma, Kiyoshi, Fujimoto, Masahiro, Dodo, Yoko, Tsujikawa, Akitaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527559/
https://www.ncbi.nlm.nih.gov/pubmed/31110273
http://dx.doi.org/10.1038/s41598-019-44078-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527559/
https://www.ncbi.nlm.nih.gov/pubmed/31110273
http://dx.doi.org/10.1038/s41598-019-44078-6

Ejemplares similares